Pharmacological research continues to make great strides forward, and innovative medicines are now being licensed and made available for inclusion in the hospital formulary. Decision makers, whether doctors, clinical pharmacologists or pharmacists must wade through a vast body of literature to properly assess the utility and benefits of new drugs.
In this new volume of the "Year in..." medical literature review series, three distinguished clinical pharmacologists have brought together a team of experts to review 12 new drugs and provide updates on pharmacoeconomics, pharmacogenetics and new developments in herbal medicine. Using the series approach of identifying and reviewing the landmark papers on each topic of the past eighteen months, each contribution provides a succinct overview that will enable the reader to quickly identify the important new developments and their impact on clinical practice, within a single volume.
This book will be of great value both to those involved with decision-making for the hospital formulary, and also to those doctors in specific disciplines who wish to keep themselves abreast of new therapeutic developments.
